US: 800.298.5699
Int'l: +1.240.747.3093
 
Matching geography
Reports matching your search in:
 
 
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!
 

Respiratory/Pulmonary Market Research Reports & Industry Analysis

RSS Feeds

Respiratory/Pulmonary Industry Research & Market Reports

1    3    5  6  7  8  9  10  
Global Non-Small Cell Lung Cancer Partnering 2010 to 2016
7/1/2016 | published by: Current Partnering
... healthcare companies. Trends in partnering deals Top deals by value Deals listed by company A-Z, industry sector, stage of development, technology type The report provides understanding and access to the partnering deals and agreements entered ...  |  read more...
USD 1,495
Global Cystic Fibrosis Partnering 2010 to 2016
7/1/2016 | published by: Current Partnering
... Trends in partnering deals Top deals by value Deals listed by company A-Z, industry sector, stage of development, technology type The report provides understanding and access to the partnering deals and agreements entered into by ...  |  read more...
USD 1,495
Global Respiratory Syncytial Virus Partnering 2010-2016
7/1/2016 | published by: Current Partnering
... in partnering deals Top deals by value Deals listed by company A-Z, industry sector, stage of development, technology type The report provides understanding and access to the partnering deals and agreements entered into by the ...  |  read more...
USD 1,495
Global Pneumonia Partnering 2010-2016
7/1/2016 | published by: Current Partnering
... deals Top deals by value Deals listed by company A-Z, industry sector, stage of development, technology type The report provides understanding and access to the partnering deals and agreements entered into by the world’s leading ...  |  read more...
USD 1,495
Acute Lung Injury - Pipeline Review, H1 2016
6/22/2016 | published by: Global Markets Direct
... information on the therapeutics under development for Acute Lung Injury, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the ...  |  read more...
USD 2,000
Respiratory Diseases: Adenovirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV, Tuberculosis - Supplier Shares, Competitive Strategies, Country Volume and Sales Segment Forecasts, Technology Trends, Instrumentation Review
6/28/2016 | published by: VPGMarketResearch.com
... presents detailed analysis of the Respiratory Disease market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on epidemiology and etiology are provided for Adenovirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, ...  |  read more...
USD 9,850
Respiratory Diseases Diagnostic Testing Market
7/1/2016 | published by: VPGMarketResearch.com
... shares, and strategic profiles of leading suppliers. About this Report This report presents detailed analysis of the Respiratory Disease market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on ...  |  read more...
USD 9,850
World Respiratory Diseases Market: Global Opportunities and Growth Strategies for Suppliers
7/8/2016 | published by: VPGMarketResearch.com
... instrumentation, sales forecasts by country, market shares, and strategic profiles of leading suppliers. About this Report This report presents detailed analysis of the Respiratory Disease market in the US, Europe (France, Germany, Italy, Spain, UK) ...  |  read more...
USD 9,850
Italy Respiratory Diseases Market: Emerging Opportunities and Growth Strategies for Suppliers
7/8/2016 | published by: VPGMarketResearch.com
... shares for Adenovirus , Influenza , Legionella , Mononucleosis , Mycoplasma , Pneumonia , RSV and Tuberculosis . The report provides test volume and sales projections for Hospitals and Commercial/Private Labs. In addition to market ...  |  read more...
USD 1,950
Japan Respiratory Diseases Market: Emerging Opportunities and Growth Strategies for Suppliers
7/8/2016 | published by: VPGMarketResearch.com
... shares for Adenovirus , Influenza , Legionella , Mononucleosis , Mycoplasma , Pneumonia , RSV and Tuberculosis . The report provides test volume and sales projections for Hospitals and Commercial/Private Labs. In addition to market ...  |  read more...
USD 2,400
US Respiratory Diseases Diagnostic Testing Market
7/1/2016 | published by: VPGMarketResearch.com
... Mononucleosis, Mycoplasma, Pneumonia, RSV and Tuberculosis. The report provides test volume and sales projections for Hospitals, Physician Offices, Commercial, and Public Health Labs. In addition to market share and sales forecasts, the report: - Examines ...  |  read more...
USD 3,600
US Respiratory Diseases: Adenovirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV, Tuberculosis - Supplier Shares by Test, Competitive Strategies, Country Volume and Sales Segment Forecasts
7/1/2016 | published by: VPGMarketResearch.com
... US respiratory disease testing market, including emerging tests, technologies, instrumentation, sales forecasts by country, market shares, and strategic profiles of leading suppliers. About this Report This report presents detailed analysis of the Respiratory Disease market ...  |  read more...
USD 4,600
Respiratory Diseases: France, Germany, Italy, Spain, UK - Market Analysis, Competitive Intelligence, Technology Trends, Opportunities for Suppliers
6/27/2016 | published by: VPGMarketResearch.com
... tests, technologies, instrumentation, sales forecasts by country, market shares, and strategic profiles of leading suppliers. About this Report This report presents detailed analysis of the Respiratory Disease market in Europe (France, Germany, Italy, Spain, UK). ...  |  read more...
USD 8,300
Europe Respiratory Diseases Market: Emerging Opportunities and Growth Strategies for Suppliers
7/8/2016 | published by: VPGMarketResearch.com
... country, market shares, and strategic profiles of leading suppliers. About this Report This report presents detailed analysis of the Respiratory Disease market in Europe (France, Germany, Italy, Spain, UK). Current scientific views on epidemiology and ...  |  read more...
USD 8,300
Respiratory Syncytial Virus (RSV): US, Europe, Japan - Market Analysis, Competitive Intelligence, Technology Trends, Opportunities for Suppliers
6/24/2016 | published by: VPGMarketResearch.com
... (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Respiratory Syncytial Virus definition, epidemiology and etiology are reviewed. The report provides the 5- and 10-year test volume and sales forecasts by country ...  |  read more...
USD 4,350
Global Idiopathic Pulmonary Fibrosis Partnering 2010 to 2016
7/1/2016 | published by: Current Partnering
... companies. Trends in partnering deals Top deals by value Deals listed by company A-Z, industry sector, stage of development, technology type The report provides understanding and access to the partnering deals and agreements entered into ...  |  read more...
USD 1,495
EpiCast Report: Idiopathic Pulmonary Fibrosis - Epidemiology Forecast to 2025
6/7/2016 | published by: GlobalData
... is characterized by variable degrees of inflammation and scarring and is associated with a histologic or radiologic pattern of usual interstitial pneumonia (UIP). IPF is the most common form of idiopathic interstitial pneumonia, having the ...  |  read more...
USD 3,995
Germany Respiratory Diseases Diagnostic Testing Market
7/1/2016 | published by: VPGMarketResearch.com
... Mononucleosis, Mycoplasma, Pneumonia, RSV and Tuberculosis. The report provides test volume and sales projections for Hospitals and Commercial/Private Labs. In addition to market share and sales forecasts, the report: - Examines market applications of Molecular ...  |  read more...
USD 1,950
Germany Respiratory Diseases Market: Emerging Opportunities and Growth Strategies for Suppliers
7/8/2016 | published by: VPGMarketResearch.com
... shares for Adenovirus , Influenza , Legionella , Mononucleosis , Mycoplasma , Pneumonia , RSV and Tuberculosis . The report provides test volume and sales projections for Hospitals and Commercial/Private Labs. In addition to market ...  |  read more...
USD 1,950
US Idiopathic Pulmonary Fibrosis Market and Competitive Landscape Highlights – 2016
4/1/2016 | published by: Fore Pharma
... Fibrosis pipeline products, Idiopathic Pulmonary Fibrosis epidemiology, Idiopathic Pulmonary Fibrosis market valuations and forecast, Idiopathic Pulmonary Fibrosis products sales and competitive landscape in the US. classified into nine sections – Idiopathic Pulmonary Fibrosis overview including ...  |  read more...
USD 990
Germany Chronic Obstructive Pulmonary Disease Market and Competitive Landscape Highlights – 2016
4/1/2016 | published by: Fore Pharma
... Chronic Obstructive Pulmonary Disease pipeline products, Chronic Obstructive Pulmonary Disease epidemiology, Chronic Obstructive Pulmonary Disease market valuations and forecast, Chronic Obstructive Pulmonary Disease products sales and competitive landscape in Germany. classified into nine sections – ...  |  read more...
USD 990
Germany Idiopathic Pulmonary Fibrosis Market and Competitive Landscape Highlights – 2016
4/1/2016 | published by: Fore Pharma
... Fibrosis pipeline products, Idiopathic Pulmonary Fibrosis epidemiology, Idiopathic Pulmonary Fibrosis market valuations and forecast, Idiopathic Pulmonary Fibrosis products sales and competitive landscape in Germany. classified into nine sections – Idiopathic Pulmonary Fibrosis overview including etiology, ...  |  read more...
USD 990
Spain Idiopathic Pulmonary Fibrosis Market and Competitive Landscape Highlights – 2016
4/1/2016 | published by: Fore Pharma
... Fibrosis pipeline products, Idiopathic Pulmonary Fibrosis epidemiology, Idiopathic Pulmonary Fibrosis market valuations and forecast, Idiopathic Pulmonary Fibrosis products sales and competitive landscape in Spain. classified into nine sections – Idiopathic Pulmonary Fibrosis overview including etiology, ...  |  read more...
USD 990
Italy Chronic Obstructive Pulmonary Disease Market and Competitive Landscape Highlights – 2016
4/1/2016 | published by: Fore Pharma
... Chronic Obstructive Pulmonary Disease pipeline products, Chronic Obstructive Pulmonary Disease epidemiology, Chronic Obstructive Pulmonary Disease market valuations and forecast, Chronic Obstructive Pulmonary Disease products sales and competitive landscape in Italy. classified into nine sections – ...  |  read more...
USD 990
Italy Idiopathic Pulmonary Fibrosis Market and Competitive Landscape Highlights – 2016
4/1/2016 | published by: Fore Pharma
... Fibrosis pipeline products, Idiopathic Pulmonary Fibrosis epidemiology, Idiopathic Pulmonary Fibrosis market valuations and forecast, Idiopathic Pulmonary Fibrosis products sales and competitive landscape in Italy. classified into nine sections – Idiopathic Pulmonary Fibrosis overview including etiology, ...  |  read more...
USD 990
1    3    5  6  7  8  9  10